Page last updated: 2024-08-25

lamifiban and Blood Loss, Surgical

lamifiban has been researched along with Blood Loss, Surgical in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carteaux, JP; Colombo, V; Hadváry, P; Kuhn, H; Roux, S; Tschopp, T	1

Other Studies

1 other study(ies) available for lamifiban and Blood Loss, Surgical

Article	Year
Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass. The Journal of thoracic and cardiovascular surgery, 1993, Volume: 106, Issue:5 Topics: Acetates; Animals; Blood Coagulation Tests; Blood Loss, Surgical; Cardiopulmonary Bypass; Dogs; Female; Fibrinogen; Hematocrit; Male; Microscopy, Electron, Scanning; Oxygenators, Membrane; Platelet Aggregation; Platelet Count; Platelet Membrane Glycoproteins; Tyrosine	1993

Article

Year

Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass.

The Journal of thoracic and cardiovascular surgery, 1993, Volume: 106, Issue:5

Topics: Acetates; Animals; Blood Coagulation Tests; Blood Loss, Surgical; Cardiopulmonary Bypass; Dogs; Female; Fibrinogen; Hematocrit; Male; Microscopy, Electron, Scanning; Oxygenators, Membrane; Platelet Aggregation; Platelet Count; Platelet Membrane Glycoproteins; Tyrosine

1993